Logo1
NW-PSHP - The 4th Annual Continuing Education Day
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.

Please rate the following:

   Overall quality of the program.

The speaker(s) was knowledgeable.
The speaker(s) was knowledgeable.
The speaker(s) was knowledgeable.
The speaker(s) was knowledgeable.
The speaker(s) was knowledgeable.
The speaker(s) was knowledgeable.
The speaker(s) was knowledgeable.
The speaker(s) was knowledgeable.

   Relevance of program for your work.

The speaker(s) was organized.
The speaker(s) was organized.
The speaker(s) was organized.
The speaker(s) was organized.
The speaker(s) was organized.
The speaker(s) was organized.
The speaker(s) was organized.
The speaker(s) was organized.

   Content matched stated objectives.

Describe infectious diseases that are preventable with recently approved adult vaccines, including pertussis, zoster, influenza and human papillomas virus.
Discuss the prevalence and complications of these diseases.
Discuss these recently approved vaccines, including their indications, contraindications, adverse effects, administration, storage and reconstitution.
Discuss the recent changes and additions to CDC guidelines for these vaccines.
Discuss current research in vaccines and vaccine administration.
Describe infectious diseases that are preventable with recently approved adult vaccines, including pertussis, zoster, influenza and human papillomas virus.
Discuss the prevalence and complications of these diseases.
Discuss these recently approved vaccines, including their indications, contraindications, adverse effects, administration, storage and reconstitution.
Describe the most common types of infections caused by CA-MRSA.
Identify the drugs most commonly used to treat infections caused by CA-MRSA.
Describe the most common side effects associated with medications used for the treatment of CA-MRSA.
Describe the most common types of infections caused by CA-MRSA.
Identify features which distinguish CA-MRSA from HA-MRSA.
Discuss the treatment options for CA-MRSA.
Discuss the significance of the D-test as it relates to the use of clindamycin for the treatment of CA-MRSA.
Describe the evidence for the migration of  CA-MRSA into the hospital setting.
Contrast the pathophysiology and clinical presentation of Ulcerative Colitis and Crohn's Disease.
Discuss potential goals of therapy and appropriate pharmacotherapeutic modalities to achieve these goals.
Review new and emerging therapies for the management of Ulcerative Colitis and Crohn's Disease.
Compare the benefits and risks associated with treatment options for Inflammatory Bowel Disease.
Discuss how the clinical presentation of ulcerative colitis differs from Crohn’s disease.
Discuss how the clinical presentation of ulcerative colitis differs from Crohn’s disease.
Identify new and emerging therapies for the management of ulcerative colitis and Crohn’s disease.
Compare the adverse reaction & drug interaction profiles of various medications used to treat inflammatory bowel disease.
Distinguish the mechanism of action of nebivolol from that of other beta blockers.
State the indications and uses of nebivolol.
Compare the effectiveness of nebivolol with other antihypertensive agents.
Identify the drug interaction related to the concurrent use of simvastatin and amiodarone.
Recall the FDA approved dosage of simvastatin when used with amiodarone.
Identify the signs and symptoms of rhabdomyolysis.
Extrapolate the use of other statins and their interaction with amiodarone.
Write a therapeutic treatment and monitoring plan for patients on amiodarone with hyperlipidemia.
Define hyponatremia and interpret pertinent laboratory values.
Identify patient symptoms and risk factors for SSRI induced hyponatremia.
Formulate a pharmacotherapeutic treatment and monitoring plan for SSRI induced hyponatremia.
Select medications, other than SSRIs, that can cause hyponatremia.
Identify the consequences of untreated hyponatremia.
Discuss dementia related psychosis.
Identify the risk factors for antipsychotic related death.
Review the literature discussing the warnings.
Identify the drug class and mechanism of action of nebivolol.
State the indications of nebivolol.
List the 3 major side effects of nebivolol.
Identify different types of statins.
Compare and contrast drug interactions associated with statins.
Identify the drug interaction between simvastatin and amiodarone.
Recall the FDA approved dosage of simvastatin when used with amiodarone.
Identify signs and symptoms of muscle pain due to the interaction of simvastatin and amiodarone.
Define hyponatremia.
Identify the medications that are considered to be SSRIs.
Identify patient symptoms of hyponatremia.
Select patient risk factors that could contribute to SSRI induced hyponatremia.
Recall the consequences of untreated hyponatremia.
Discuss dementia related psychosis.
Review death as a potential adverse event of antipsychotics.
Discuss the impact that the warning may have.

   Usefulness of handouts/AV.

   Teaching methods were appropriate.

   Presenter(s).

Please use this space to give us additional comments about the presenters.

Were your professional or personal expectations met during the conference?

What did you learn that you are likely to put into practice once you return to work?

Please list any professional practice "gaps" / educational needs you would like to see addressed in future meetings.

Mr question